Cabenuva Kit
Product Images NDC 49702-240

Product Visual Gallery

This gallery contains 50 technical images submitted to the FDA as part of the official labeling for Cabenuva (NDC 49702-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cabotegravir Chemical Structure (Cabenuva Spl Graphic 01)

Chemical structure of the active ingredient cabotegravir from the prescription drug Cabenuva (cabotegravir and rilpivirine) kit by ViiV Healthcare Company.*

FDA Label Image

Rilpivirine Chemical Structure (Cabenuva Spl Graphic 02)

Chemical structure diagram showing the molecular formula of cabotegravir, one of the active ingredients in Cabenuva, a human prescription drug kit by ViiV Healthcare Company. The structure includes aromatic rings, nitrogen atoms, and cyano groups.*

FDA Label Image

Cabenuva Instructions For Use 400mg_600mg Kit (Cabenuva Spl Graphic 03)

Packaging label for Cabenuva kit by ViiV Healthcare Company, containing cabotegravir extended-release injectable suspension 400 mg/2 mL (200 mg/mL) and rilpivirine extended-release injectable suspension 600 mg/2 mL (300 mg/mL). Label indicates use for gluteal intramuscular injection and is for healthcare professional administration only.*

FDA Label Image

Contents Of Kit (Cabenuva Spl Graphic 04)

An instructional diagram showing components of the Cabenuva kit by ViiV Healthcare Company. It depicts labeled cabotegravir and rilpivirine vials, vial adapters, syringes with plungers, syringe labels, and injection needles with needle guards and caps, illustrating parts included for preparation and administration.*

FDA Label Image

Figure A (Cabenuva Spl Graphic 05)

An instructional illustration showing a gloved hand holding a small vial with a syringe attached. The image highlights the location of the expiration date on the vial label, accompanied by the text "Check expiration date and medicine." The expiration date is shown in a magnified circular inset as "EXP MMYYYY."*

FDA Label Image

Figure B (Cabenuva Spl Graphic 06)

An instructional illustration showing two medicine vials side by side with an orange clock icon and text indicating to wait 15 minutes, likely representing a preparation or administration step for a drug kit.*

FDA Label Image

Figure C (Cabenuva Spl Graphic 07)

Instructional illustration showing step-by-step hand movements for preparing an injectable dose using a vial and a small container, indicating a 10-second rotation or shaking motion. The hands wear purple gloves, demonstrating proper technique for handling the medication components in the Cabenuva kit by ViiV Healthcare Company.*

FDA Label Image

Figure D (Cabenuva Spl Graphic 08)

An instructional illustration showing two gloved hands removing the protective cap from a small vial, demonstrating vial preparation or medication access steps commonly associated with injectable drug administration.*

FDA Label Image

Figure E (Cabenuva Spl Graphic 09)

An instructional illustration showing hands wearing gloves peeling back a protective foil or seal from a circular medication device or vial, demonstrating the process of opening a medication component, presumably part of the Cabenuva kit.*

FDA Label Image

Figure F (Cabenuva Spl Graphic 10)

An instructional illustration showing hands interacting with a vial as part of medication preparation. The first panel shows a hand pressing down on the vial's cap. The second panel shows the cap being lifted off after pressing down, indicated by upward and downward orange arrows.*

FDA Label Image

Figure G (Cabenuva Spl Graphic 11)

An illustration showing hands holding a syringe with a label pointing to 1 mL of air inside the syringe. An orange arrow points downward below the syringe, indicating an action related to the syringe plunger.*

FDA Label Image

Figure H (Cabenuva Spl Graphic 12)

An instructional illustration showing the preparation of a vial and syringe. The left side depicts twisting a cap off the vial while holding it steady; the right side shows pressing the syringe plunger downward to dispense or draw fluid. The illustration uses simple, clear lines and arrows to indicate motion.*

FDA Label Image

Figure I (Cabenuva Spl Graphic 13)

An instructional illustration showing a gloved hand holding a vial and pushing a syringe plunger downward into it. The image includes an orange arrow pointing downward, indicating the direction to push the plunger, likely demonstrating how to draw medication from the vial.*

FDA Label Image

Figure J (Cabenuva Spl Graphic 14)

An instructional illustration showing a gloved hand removing or twisting the cap off a vial while holding a syringe with the other gloved hand. Orange arrows indicate a twisting or turning motion to open the vial; the image demonstrates preparation of a dose using a vial and syringe, likely related to Cabenuva injection kit usage.*

FDA Label Image

Figure K (Cabenuva Spl Graphic 15)

An instructional illustration showing hands wearing purple gloves preparing a syringe by removing or unfolding a protective cover from its needle or vial attachment. The action involves pulling or twisting upward indicated by orange arrows.*

FDA Label Image

Figure L (Cabenuva Spl Graphic 16)

An instructional illustration showing proper injection site placement on the upper arm. A purple-gloved hand points to a section on the upper arm marked with an orange band and a cross, indicating the correct location for administering an intramuscular injection, with an adjacent mark showing an incorrect site position.*

FDA Label Image

Figure M (Cabenuva Spl Graphic 17)

An instructional illustration showing a pair of gloved hands holding a syringe while peeling back a protective cover from the needle, demonstrating how to prepare the syringe for injection.*

FDA Label Image

Figure N (Cabenuva Spl Graphic 18)

An instructional illustration showing a hand holding a syringe with a needle and a cap being removed. The syringe is marked with a volume measurement of 2 mL, indicated by an orange arrow pointing upward along the syringe barrel.*

FDA Label Image

Figure O (Cabenuva Spl Graphic 19)

An instructional diagram showing a hand wearing a glove positioned about 1 inch (2.5 cm) away from a marked spot on skin. The illustration appears to guide proper placement or measurement on the skin, possibly for drug administration or injection site preparation.*

FDA Label Image

Figure P (Cabenuva Spl Graphic 20)

Instructional illustration showing the administration of an injection using a syringe and needle into a patient's skin. A hand is pressing down on the syringe plunger, indicated by a downward orange arrow, while the other hand steadies the patient's skin at the injection site.*

FDA Label Image

Figure Q (Cabenuva Spl Graphic 21)

An instructional illustration showing the proper technique for administering an injection. A gloved hand is holding a syringe perpendicular to a patient's skin, with an orange arrow indicating the direction of injection downward into the skin.*

FDA Label Image

Figure R (Cabenuva Spl Graphic 22)

An illustration showing a gloved hand placing a small adhesive patch or bandage on skin, likely demonstrating application or aftercare related to a drug product.*

FDA Label Image

Figure S (Cabenuva Spl Graphic 23)

Instructional illustration showing a purple-gloved hand inserting a needle into a safety device by rotating it with an orange arrow indicating the direction and a 'click' sound effect confirming proper attachment. The image demonstrates the preparation step for using an injection device, likely part of the Cabenuva kit.*

FDA Label Image

Figure T (Cabenuva Spl Graphic 24)

An instructional illustration showing a gloved hand disposing of a syringe into a labeled sharps disposal container. The image emphasizes safe needle disposal practices with a downward arrow indicating placement of the syringe into the container.*

FDA Label Image

Figure U (Cabenuva Spl Graphic 25)

An instructional diagram showing an orange circular arrow with the text "Repeat all steps for 2nd medicine." This image likely indicates a step in a medication administration or preparation process requiring repetition for a second drug.*

FDA Label Image

Cabenuva Instructions For Use 600mg_900mg Kit (Cabenuva Spl Graphic 26)

Cabenuva kit label showing the drug name and pronunciation guide. It contains cabotegravir extended-release injectable suspension 600 mg/3 mL (200 mg/mL) and rilpivirine extended-release injectable suspension 900 mg/3 mL (300 mg/mL). It is indicated for gluteal intramuscular use and healthcare professional administration only. The label includes the ViiV Healthcare Company logo.*

FDA Label Image

Contents Of Kit (Cabenuva Spl Graphic 27)

An instructional diagram showing components of the Cabenuva kit by ViiV Healthcare Company. It includes illustrations of the cabotegravir vial with vial cap, rilpivirine vial with vial cap, two vial adapters, two syringes with plungers, syringe labels, and injection needles with needle guards and caps.*

FDA Label Image

Figure A (Cabenuva Spl Graphic 28)

An instructional illustration showing a hand holding a single-dose vial with a zoomed inset highlighting the location of the expiration date on the vial label. The text advises to check the expiration date and medicine before use.*

FDA Label Image

Figure B (Cabenuva Spl Graphic 29)

An instructional illustration showing two vials, one with an orange cap and the other with a yellow cap, accompanied by text and a clock icon indicating to wait 15 minutes. This likely relates to preparation or administration timing for the Cabenuva kit containing cabotegravir and rilpivirine.*

FDA Label Image

Figure C (Cabenuva Spl Graphic 30)

An instructional illustration showing a hand wearing a purple glove shaking a vial for 10 seconds, depicted through multiple hand positions with arrows indicating motion. Another hand image shows the vial held upright for use. This likely demonstrates preparation steps for use of a medication kit.*

FDA Label Image

Figure D (Cabenuva Spl Graphic 31)

An instructional illustration showing hands wearing gloves opening a vial by lifting a flip-off cap. This image is likely demonstrating a step in the preparation or administration process for the Cabenuva kit containing cabotegravir and rilpivirine.*

FDA Label Image

Figure E (Cabenuva Spl Graphic 32)

An instructional illustration showing hands wearing purple gloves peeling back the foil seal from a vial or container, demonstrating the proper way to open the product packaging or vial top.*

FDA Label Image

Figure F (Cabenuva Spl Graphic 33)

Illustration showing hands opening a vial by pressing down and twisting off the cap, demonstrating vial preparation steps for the Cabenuva kit by ViiV Healthcare Company.*

FDA Label Image

Figure G (Cabenuva Spl Graphic 34)

An instructional illustration showing two hands holding a syringe. One hand is pulling the plunger down to draw in 1 mL of air, indicated by an orange arrow and text. The syringe is positioned vertically with the needle end at the top.*

FDA Label Image

Figure H (Cabenuva Spl Graphic 35)

An instructional illustration showing hands preparing a syringe with a vial. The left side demonstrates twisting the vial cap to open it, while the right side shows pressing the syringe plunger down. The image likely relates to medication preparation steps for an injectable drug kit.*

FDA Label Image

Figure I (Cabenuva Spl Graphic 36)

An instructional illustration showing gloved hands preparing a syringe by pulling down on the plunger to draw liquid medication from a vial. The image demonstrates proper technique for injectable drug preparation, likely related to the Cabenuva kit by ViiV Healthcare.*

FDA Label Image

Figure J (Cabenuva Spl Graphic 37)

Instructional illustration showing two gloved hands preparing a syringe by attaching or twisting on a vial or cap, indicated by two orange curved arrows demonstrating the rotational action.*

FDA Label Image

Figure K (Cabenuva Spl Graphic 38)

An instructional illustration showing a person wearing purple gloves preparing a syringe by extracting medication from a vial or packet. The image includes orange arrows indicating the motion of pulling back the capsule or cap to access the medication for injection.*

FDA Label Image

Figure L (Cabenuva Spl Graphic 39)

An instructional diagram showing the correct placement for an intramuscular injection into the gluteal area. The image highlights the anatomical landmarks on a gluteus with an overlay of a gloved hand indicating the safe injection site, marked by an orange dot and lines, while a crossed-out area marks where not to inject.*

FDA Label Image

Figure M (Cabenuva Spl Graphic 40)

Illustration showing hands with gloves removing a cap from a syringe by pulling and rotating it downward. The image likely demonstrates a step in preparing an injectable medication, such as the Cabenuva kit containing cabotegravir and rilpivirine.*

FDA Label Image

Figure N (Cabenuva Spl Graphic 41)

An instructional illustration showing a hand pulling back a syringe plunger to fill the syringe with 3 mL of fluid. An arrow indicates the direction to pull the plunger. The volume marking '3 mL' is highlighted near the syringe barrel.*

FDA Label Image

Figure O (Cabenuva Spl Graphic 42)

An instructional illustration showing a close-up of a hand with a purple glove touching skin near a marked spot labeled with an 'X'. An arrow indicates a distance of 1 inch (2.5 cm) away from the marked spot, suggesting measurement or placement guidance.*

FDA Label Image

Figure P (Cabenuva Spl Graphic 43)

An instructional illustration showing hands administering an injection with a syringe and needle into a person's skin. The image includes a downward orange arrow indicating the direction to push the syringe plunger to deliver the injection.*

FDA Label Image

Figure Q (Cabenuva Spl Graphic 44)

An instructional illustration showing a hand administering an intramuscular injection with a syringe and needle into the upper thigh or hip area of a patient. The image features a downward orange arrow indicating the direction of injection.*

FDA Label Image

Figure R (Cabenuva Spl Graphic 45)

An illustration showing a hand wearing a purple glove applying or removing a small adhesive patch or bandage on skin. The image demonstrates proper skin application or post-injection care technique.*

FDA Label Image

Figure S (Cabenuva Spl Graphic 46)

An instructional illustration showing a hand wearing a purple glove activating a syringe safety mechanism. The first panel shows the hand pressing down on a sheath to unlock it; the second panel shows the safety cap snapping into place with a 'click' sound indication.*

FDA Label Image

Figure T (Cabenuva Spl Graphic 47)

An illustration showing a hand wearing a glove disposing of a needle into a sharps disposal container. The container is labeled "SHARPS DISPOSAL CONTAINER" with an orange downward arrow indicating where to insert the needle.*

FDA Label Image

Figure U (Cabenuva Spl Graphic 48)

An instructional illustration showing two curved orange arrows forming a cycle with the text "Repeat all steps for 2nd medicine" in orange, indicating a repeated action in a medication process for a kit.*

FDA Label Image

Cabenua 400 mg-600mg Carton (Cabenuva Spl Graphic 49)

Cabenuva kit packaging label showing cabotegravir extended-release injectable suspension 400 mg/2 mL and rilpivirine extended-release injectable suspension 600 mg/2 mL. Label includes storage instructions, contents listing single-dose vials, syringes, needles, and information leaflets. Labeled for gluteal intramuscular use by healthcare professionals only. Manufactured by ViiV Healthcare.*

FDA Label Image

Cabenua 600 mg-900mg Carton (Cabenuva Spl Graphic 50)

Cabenuva 600 mg/900 mg Kit packaging label from ViiV Healthcare. It contains cabotegravir extended-release injectable suspension 600 mg/3 mL and rilpivirine extended-release injectable suspension 900 mg/3 mL, each in single-dose vials. The kit includes vial adapters, syringes, injection needles, syringe labels, prescribing information, patient information, and instructions for use. Storage instructions specify refrigeration at 2°C to 8°C and handling guidelines prior to administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.